Term sheet with Universal Capital, LLC to fund HOPE Therapeutics clinic acquisition strategy Funding tied to already-announced acquisitions, with additional tranches contemplated for further growth, subject to standard due diligence Together with previously announced term sheet with a strategic investor, HOPE funding of $10.3 million is planned in the near term MIAMI , May 15, 2025 /PRNewswire/ -- HOPE Therapeutics™, Inc. ("HOPE"), a multi-site clinical care delivery organization and wholly-owned subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, today announced signing of a term sheet with Universal Capital, LLC ("Universal") to provide $7.8 million in acquisition capital …

Paycom is a top revenue grower in the SaaS HCM industry, compounding sales at 20% annually over five years. Despite a 2023 setback due to Beti's cannibalization, Paycom is poised for growth with a 25% EBITDA margin and 8% projected growth in 2025. Paycom's single-system interface and high client retention rate create a small switching moat in a competitive industry, making it a buy.

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders.

The world's largest retailer warned it's facing a dynamic environment as it withheld a profit forecast for the current quarter.

There are plenty of bargains to be had amid intense stock market volatility. And while the best deals have mostly evaporated, there are still intriguing, cheap names with timely catalysts that still look to be worth buying on the way up.

It is believed that an industry downturn could be an ideal time to load up on stocks.

Palantir Technologies Inc. is now the most expensive mega-cap ever, priced for perfection with a P/E over 200x and a strong AI growth narrative. Current fundamentals and guidance support robust growth, but not enough to fully justify the extreme valuation without a major positive surprise. Palantir's unique government position, high margins, and AI leadership are key strengths, but competitive risks and margin pressure loom.

Why IAC Is A Better Bet Than MGM Resorts

UnitedHealth Group stock has plummeted since my last Buy rating and is ~55% off highs, but its lower valuation now offers a significant margin of safety, making it a Buy. Disappointing Q1-2025 results and unexpected CEO changes have hurt the stock, but Stephen Hemsley's return as CEO should bring stability and experience. A DOJ probe against UnitedHealth adds to the risks and downside potential. However, I'm willing to take this risk at a "derisked" valuation.

Chuck Robbins, CISCO chairman and CEO, joins CNBC's 'Squawk on the Street' to discuss the company's most recent earnings.

Foot Locker (FL) shares are soaring after the footwear retailer agreed to be purchased by Dick's Sporting Goods (DKS) in a multibillion-dollar deal.

Taysha Gene Therapies, Inc. (TSHA) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.10 per share a year ago.

Bitcoin Depot Inc. (BTM) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to loss of $0.25 per share a year ago.

EDAP TMS S.A. (OTCPK:HAGHY) Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ET Company Participants John Fraunces - IR, LifeSci Advisors Ryan Rhodes - CEO Ken Mobeck - CFO Conference Call Participants Michael Sarcone - Jefferies Sean Lee - H.C.

United States wine cooler market growth is fueled by rising wine consumption in American homes, prompting consumers to spend on wine coolers for safe storage. In addition, the increasing need for high-end wine cooler storage and the expanding use of home entertainment drive the market's growth. United States wine cooler market growth is fueled by rising wine consumption in American homes, prompting consumers to spend on wine coolers for safe storage. In addition, the increasing need for high-end wine cooler storage and the expanding use of home entertainment drive the market's growth.

Mersana Therapeutics, Inc. (NASDAQ:MRSN ) Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ET Company Participants Jason Fredette - Senior Vice President, Investor Relations & Corporate Communications Marty Huber - President & Chief Executive Officer Brian DeSchuytner - Chief Operating Officer & Chief Financial Officer Conference Call Participants Tara Bancroft - TD Cowen Charles Zhu - LifeSci Capital Michael Schmidt - Guggenheim Jonathan Chang - Leerink Partners Colleen Kusy - Baird Andy Hsieh - William Blair Karina Rabayeva - Truist Jeet Mukherjee - BTIG Operator Good morning, and welcome to Mersana Therapeutics First Quarter 2025 Conference Call. Currently …

FRAMINGHAM, Mass. & CLEVELAND, Texas--(BUSINESS WIRE)--Ameresco, Inc., (NYSE: AMRC), a leading energy solutions provider dedicated to helping customers navigate the energy transition, today announced the completion of a water infrastructure modernization project for the City of Cleveland, Texas. The project kicked off in 2024 and is estimated to generate over $2.5 million in positive cash flow for the City over a 15-year term. The contract includes the replacement and installation of failed met.

Recently, Zacks.com users have been paying close attention to Intuit (INTU). This makes it worthwhile to examine what the stock has in store.

Southern Copper (SCCO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

TJX (TJX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.